Ashley Cordova $NVCR SEC Form 4 Insider Trading

Ashley Cordova has filed a total of 21 insider trades in $NVCR since 2021. Their most recent trade was a purchase of 81,550 shares, made on Sep 05, 2025. Their largest trade was a purchase of 81,550 shares, made on Sep 05, 2025. We estimate that they now own 356,019 shares of $NVCR, worth an estimated $5.9 million.

Insider Trading at $NVCR

There have been a total of 183 insider trades reported at $NVCR since 2021, with 106,524 shares purchased and 620,911 shares sold. The most active insider traders in $NVCR stock have been Frank X Leonard, Frank X Leonard, and Ashley Cordova. The most recent trade was a purchase of 81,550 shares reported by Ashley Cordova (Chief Executive Officer), made on Sep 05, 2025.

$NVCR Executives and Stock Owners with Insider Trades

• Frank X Leonard, Chief Development Officer

• Frank X Leonard, President, CNS Cancers US

• Ashley Cordova, Chief Financial Officer

• Asaf Danziger, Chief Executive Officer

• Wilhelmus Cm Groenhuysen, Chief Operating Officer

• Pritesh Shah, Chief Commercial Officer

• William Patrick Burke, Chief Human Resources Officer

• Frank X Leonard, EVP, Pres., Novocure Oncology

• Ely Benaim, Chief Medical Officer

• Pritesh Shah, Chief Growth Officer

• Mukund Paravasthu, Chief Operating Officer

• Ashley Cordova, Chief Executive Officer

• Uri Weinberg, Chief Science Officer

• Michal Nath Puri, Chief Human Resources Officer

• Todd Christopher Longsworth, General Counsel

• Christoph Brackmann, Chief Financial Officer

• William F Doyle, Executive Chairman

• Nicolas Leupin, Chief Medical Officer

• Uri Weinberg, Chief Innovation Officer

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.